Iterum Therapeutics plc financial data

Symbol
ITRM on Nasdaq
Location
Dublin 1, Ireland
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 202% % 81%
Quick Ratio 8% %
Debt-to-equity -905% % -185%
Return On Equity 602% % 72%
Return On Assets -75% % 53%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44,656,906 shares 97%
Entity Public Float $19,200,000 USD 40%
Common Stock, Value, Issued $490,000 USD 116%
Weighted Average Number of Shares Outstanding, Basic 45,801,927 shares 129%
Weighted Average Number of Shares Outstanding, Diluted 45,801,927 shares 129%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $390,000 USD
Research and Development Expense $4,151,000 USD -78%
General and Administrative Expense $10,858,000 USD 43%
Operating Income (Loss) $20,640,000 USD 22%
Nonoperating Income (Expense) $6,045,000 USD -62%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $26,685,000 USD 12%
Income Tax Expense (Benefit) $276,000 USD -23%
Net Income (Loss) Attributable to Parent $26,961,000 USD 12%
Earnings Per Share, Basic 0 USD/shares 65%
Earnings Per Share, Diluted 0 USD/shares 65%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $11,002,000 USD -18%
Accounts Receivable, after Allowance for Credit Loss, Current $448,000 USD
Inventory, Net $1,149,000 USD
Assets, Current $13,727,000 USD -13%
Property, Plant and Equipment, Net $18,000 USD -40%
Operating Lease, Right-of-Use Asset $0 USD -100%
Intangible Assets, Net (Excluding Goodwill) $18,710,000 USD
Other Assets, Noncurrent $19,000 USD
Assets $32,503,000 USD 104%
Accounts Payable, Current $577,000 USD -31%
Employee-related Liabilities, Current $882,000 USD -50%
Accrued Liabilities, Current $5,216,000 USD 49%
Liabilities, Current $6,430,000 USD -66%
Operating Lease, Liability, Noncurrent $16,000 USD -99%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $39,884,000 USD 45%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $506,451,000 USD -5.6%
Stockholders' Equity Attributable to Parent $7,381,000 USD 36%
Liabilities and Equity $32,503,000 USD 104%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,060,000 USD 77%
Net Cash Provided by (Used in) Financing Activities $8,388,000 USD -216%
Net Cash Provided by (Used in) Investing Activities $7,211,000 USD 41%
Common Stock, Shares Authorized 80,000,000 shares 0%
Common Stock, Shares, Issued 48,991,860 shares 116%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,473,000 USD -970%
Deferred Tax Assets, Valuation Allowance $44,614,000 USD 6.9%
Operating Lease, Liability $20,000 USD -96%
Depreciation $7,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $2,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $26,963,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid $20,000 USD -96%
Property, Plant and Equipment, Gross $109,000 USD -70%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two $18,000 USD -96%
Lessee, Operating Lease, Liability, to be Paid, Year One $20,000 USD -95%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -23%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,000 USD -83%
Deferred Tax Assets, Operating Loss Carryforwards $44,536,000 USD 7.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $1,909,000 USD -5.5%
Operating Lease, Payments $152,000 USD -62%
Additional Paid in Capital $498,580,000 USD
Amortization of Intangible Assets $349,000 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%